Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Terumo claims antithrombotic/antiallergy agents

Aug. 23, 1996

Fibrinogen antagonists in SmithKline Beecham's pipeline

Aug. 23, 1996

Corvas describes Factor Xa inhibitors

Aug. 23, 1996

More thrombin inhibitors from BioChem Pharma

Aug. 23, 1996

BioChem Pharma claims thrombin inhibitors for coagulopathies

Aug. 23, 1996

Coagulation factor X inhibitors described by Yamanouchi

Aug. 16, 1996

Sanofi describes fibrinogen antagonists

Aug. 16, 1996

Fibrinogen antagonists claimed by Toyama

Aug. 16, 1996

SKB reports fibrinogen antagonists

Aug. 16, 1996

Anticoagulant hirudin analogue NF-22 designated developmental candidate

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...